BioScience Health Innovations, Inc.
BHIC
$6.40
$2.1048.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 208.34% | 207.22% | 260.04% | 231.53% | 208.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 208.34% | 207.22% | 260.04% | 231.53% | 208.73% |
| Cost of Revenue | 356.72% | 417.72% | 565.10% | 445.04% | 373.92% |
| Gross Profit | 147.59% | 149.32% | 190.27% | 184.88% | 170.21% |
| SG&A Expenses | 106.37% | 81.74% | 75.44% | 51.57% | 66.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.69% | 156.09% | 161.09% | 106.81% | 107.04% |
| Operating Income | 726.44% | 2,194.56% | 1,372.69% | 342.19% | 134.59% |
| Income Before Tax | 726.44% | 2,194.56% | 1,372.69% | 342.19% | 134.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 638.05% | 2,194.56% | 1,372.69% | 342.19% | 134.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 638.05% | 2,194.56% | 1,372.69% | 342.19% | 134.59% |
| EBIT | 726.44% | 2,194.56% | 1,372.69% | 342.19% | 134.59% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 613.41% | 2,205.71% | 1,243.42% | 324.46% | 121.30% |
| Normalized Basic EPS | 673.58% | 2,095.65% | 1,282.61% | 326.21% | 121.99% |
| EPS Diluted | 667.57% | 1,695.92% | 627.50% | 262.46% | 115.78% |
| Normalized Diluted EPS | 710.00% | 2,400.00% | 1,242.55% | 322.76% | 120.75% |
| Average Basic Shares Outstanding | 4.57% | 5.54% | 5.30% | 5.01% | 24.57% |
| Average Diluted Shares Outstanding | 2.76% | 5.73% | 7.58% | 7.60% | 27.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |